New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
08:41 EDTSONC, LLY, FINL, FOLD, LULU, ARAY, AUO, FLOn The Fly: Pre-market Movers
HIGHER AFTER GUIDANCE: Eli Lilly (LLY), up 1.7%... ALSO HIGHER: Amicus Theraputics (FOLD), up 8.5% after announcing results from Phase 2 study... AU Optronics (AUO), up 4.7% after DigiTimes said company asked to join Amazon supply chain... LOWER AFTER EARNINGS/GUIDANCE: Finish Line (FINL), down 7%... Sonic (SONC), down 5%... Accuray (ARAY), down 25.5%... ALSO LOWER: Foot Locker (FL), down 2% after disappointing results, guidance of peer Finish Line... lululemon (LULU), down 3.9% after downgrade to Neutral at Credit Suisse.
News For FINL;FL;LULU;LLY;AUO;FOLD;SONC;ARAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
June 25, 2015
06:07 EDTLLYEli Lilly reports UK court rules in favor of Lilly in Alimta vitamin patent suit
Eli Lilly announced that the Court of Appeal has ruled that the Alimta vitamin regimen patent would be indirectly infringed by a generic competitor that had stated its intent to market certain alternative salt forms of pemetrexed in the United Kingdom prior to the UK patent's expiration in June 2021. Specifically, the Court of Appeal held that commercialization of these alternative salt forms in the products as proposed would constitute indirect infringement by supplying an essential means for putting the patented invention into effect. The decision came in the case of Actavis v. Eli Lilly and Company. The Court of Appeal also held there was no difference between the law in the UK and that in France, Italy and Spain as it relates to indirect infringement, and so reversed the High Court's decision granting declarations of noninfringement over the Alimta vitamin regimen patents in those countries. Actavis may seek permission to appeal the decision to the UK Supreme Court. In addition, Actavis has stated it may ask the High Court to decide whether a different proposed product would infringe the patent. The Court of Appeal has ruled that the High Court will need to decide whether it will hear this new claim. If the High Court decides to hear Actavis' case on the different proposed product, Lilly will defend the case vigorously. In Europe, the compound patents for Alimta remain in force and are expected to provide exclusivity through December 2015. This decision increases the likelihood that the vitamin regimen patents for Alimta will provide exclusivity in the UK, France, Italy and Spain through June 2021.
June 24, 2015
17:18 EDTFLChamps Sports, Under Armour launch premium store-within-store concept
Champs Sports, a member of the Foot Locker (FL) family, is collaborating with Under Armour (UA) to launch The ARMOURY at Champs Sports. This is the first-of-its-kind, premium store-within-a-store and will open later this month at the Champs Sports store in The Mall in Columbia in Columbia, MD.
13:52 EDTFINLFinish Line volatility elevated into Q1 and outlook
Finish Line July call option implied volatility is at 49, August is at 36, November is at 34; compared to its 52-range-week of 24 to 49, suggesting large price movement into the expected release of Q1 results on June 25.
June 23, 2015
13:37 EDTSONCOn The Fly: Top stock stories at midday
Subscribe for More Information
10:46 EDTSONCSonic sees $70M-$80M of free cash flow in FY15
Subscribe for More Information
09:14 EDTSONCOn The Fly: Pre-market Movers
Subscribe for More Information
08:45 EDTSONCSonic revenue momentum impressive, says Sterne Agee CRT
Subscribe for More Information
07:53 EDTSONCSonic reported 'very solid' results, says Oppenheimer
Subscribe for More Information
07:15 EDTSONCOppenheimer to hold a conference
Subscribe for More Information
June 22, 2015
19:00 EDTSONCOn The Fly: After Hours Movers
Subscribe for More Information
17:46 EDTSONCSonic slides over 5% after reporting Q3 results and guidance
Subscribe for More Information
16:07 EDTSONCSonic sees Q4 positive same-store sales in the mid-single digit range
Subscribe for More Information
16:05 EDTSONCSonic sees 27%-29% EPS growth in FY15
Subscribe for More Information
16:04 EDTSONCSonic reports adjusted Q3 EPS 36c, consensus 36c
Reports Q3 revenue $164.7M, consensus $164.17M. Reports Q3 system same-store sales increased 6.1%, consisting of a 6.1% same-store sales increase at franchise drive-ins and an increase of 5.5% at company drive-ins.
15:00 EDTSONCNotable companies reporting after market close
Subscribe for More Information
13:46 EDTSONCSonic technical notes before earnings news
Subscribe for More Information
11:31 EDTLLYActinobac Biomed signs licensing agreemnt with Eli Lilly unit Elanco
Subscribe for More Information
10:36 EDTFLFoot Locker management to meet with FBN Securities
Subscribe for More Information
08:39 EDTLLYBernstein pharmaceuticals analyst holds an analyst/industry conference call
Subscribe for More Information
06:02 EDTLULUStocks with implied volatility below IV index mean; QIHU LULU
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use